Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: Interleukin-2
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
Eva Bonetti, Maximilian Jenzer, Cathleen Nientiedt, Adam Kaczorowski, Christine Geisler, Stefanie Zschäbitz, Dirk Jäger, Markus Hohenfellner, Stefan Duensing, Philipp Reimold
Journal:
Urologia Internationalis
Urol Int (2022) 106 (11): 1158–1167.
Published Online: 27 April 2022
... of multimodal treatment approaches over a 30-year period in 156 patients with advanced RCC treated with subcutaneous (s.c.) interleukin-2 (IL-2) and interferon-α (IFN-α) between 1990 and 2009. Results: The median progression-free survival following the first IT was 5.8 months with a wide range from 0 to 197...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1991) 47 (4): 219–230.
Published Online: 03 February 2010
...M. Wirth Cytokines such as interferons, interleukin-2 and tumor necrosis factor have been widely tested in the treatment of advanced renal cell cancer. However, the rates of objective remissions (PR and CR) are disappointing and rarely exceed 20% overall. Until now, a definitive cure of a patient...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1994) 53 (1): 6–11.
Published Online: 03 February 2010
... survivals were dependent upon CYC treatment being combined with tumor vaccine and/or interleukin-2; single agent treatments were ineffective. 18 11 1993 17 01 1994 3 2 2010 © 1994 S. Karger AG, Basel 1994 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1991) 47 (Suppl. 1): 83–85.
Published Online: 03 February 2010
...T. Nishimura; Y. Terashima; T. Hattori; M. Satoh; Y. Kondo; G. Kimura; K. Yoshida; M. Akimoto We studied subsets and cytotoxicity of recombinant interleukin-2 (rIL-2)-expanded tumor-infiltrating lymphocytes (TIL) from renal cell cancer (RCC) patients. TIL were successfully expanded in 13 of 14 RCC...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1991) 46 (3): 304–308.
Published Online: 02 February 2010
..., or radiation therapy to control symptoms. Metastatic renal cell cancer was often resistant to these agents. With the advent of biological response modifiers, an entirely different approach is now available. Both recombinant human interferon-alpha (IFA-α) and interleukin-2 (IL-2) have significant activity...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2006) 76 (3): 256–263.
Published Online: 06 April 2006
... for such an approach. Patients and Methods: A retrospective analysis of 57 patients who received interleukin-2, interferon-α, and 5-fluorouracil immunochemotherapy for metastatic renal cell carcinoma was conducted. Before undergoing immunochemotherapy, 20 of the 57 patients had received metastatectomy along...
Journal Articles
Subject Area:
Further Areas
Veronica Bordin, Luisa Giani, Sofia Meregalli, Roberta Bukovec, Massimo Maria Vaghi, Mario Mandalà, Franco Paolorossi, Antonio Ardizzoia, Gabriele Tancini, Sandro Barni, Franco Frigerio, Luca Fumagalli, Arrigo Bordoni, Gianni Valsuani, Greta Di Felice, Paolo Lissoni
Journal:
Urologia Internationalis
Urol Int (2000) 64 (1): 3–8.
Published Online: 20 April 2000
.... Immunotherapy Interleukin-2 Renal cell cancer Original Paper Urol Int 2000;64:3 8 Received: May 31, 1999 Accepted after revision: October 21, 1999 Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients Veronica Bordin a Luisa...
